buprenorphine
Stepping over the line
Administration of Long Acting Injectable Buprenorphine injections by pharmacists has been a ‘quantum shift’ in the profession’s scope of practice Long Acting Injectable Buprenorphine (LAIB) has been a revolution in …
Looking at harm minimisation
Methadone, buprenorphine, drug testing, naloxone and more: we discuss the latest views and opinions with a panel of experts Why is the naloxone program not seeing wider take-up? Should pharmacists …
Harm minimisation: what’s the role of pharmacy?
Vaping, buprenorphine, drug testing, naloxone and more: Angelo Pricolo gets the latest views from harm minimisation experts Why is the naloxone program not seeing wider take-up? Should pharmacists be able …
Promising results for extended-release buprenorphine
A study has shown high treatment retention and adherence, reduced substance use and depression, and improved quality of life among those receiving monthly BUP-XR Community use of long-acting buprenorphine has …
Addiction: how do we minimise harm?
Angelo Pricolo hosts a panel of experts who answer our readers’ questions about addiction medicine and pharmacy’s role in harm minimisation AJP invited a panel of leading addiction medicine experts …
The opioid snapshot
New data reveals the largest increase for a decade in the number of patients receiving opioid dependency treatment On a snapshot day in 2020, over 53,300 clients received pharmacotherapy treatment …
Opioid intervention coverage ‘woefully inadequate’
It would be “fantastic” if more pharmacists were willing to provide opioid replacement therapy, says leading researcher Latest data estimates that 40.5 million people across the world were dependent on …
RB to pay over $2 billion in opioids case
To resolve potential criminal liability stemming from conduct alleged in the indictment of a former subsidiary in the United States, RB Group will forfeit nearly one billion in proceeds and …
How did the codeine upschedule change use?
Latest data reveals a decline in use of low-dose codeine in 2018, but is there more to the story? UNSW’s National Drug & Alcohol Research Centre (NDARC) has released the …
Knowing the risks
An inquest has highlighted the importance of careful decisions in drug withdrawal, after a patient died from being administered an excessive amount of buprenorphine In April 2015, a 38-year-old man …
Research Roundup
Digoxin, opioids, yoga… Debbie Rigby takes a look at the latest in research news Digoxin and Mortality in Patients With Atrial Fibrillation In patients with AF taking digoxin, the risk …